The above referenced draft document was released by the ICH Management Committee for consultation and is being posted on the ICH website for information and comment in accordance with the ICH process.
This consultation is open for comment starting February 2, 2017 until March 11, 2017. Please select and read through the link below titled "consultation document". Once read, please submit your comments via email, fax or by mail to:
Health Canada ICH Secretariat
Biologics & Genetic Therapies Directorate
Health Products and Food Branch
100 Eglantine Driveway, Tunney's Pasture
Interested parties are encouraged to provide comments and suggestions by March 11, 2017.
Health Canada will make the results of this consultation available on this Web site.
If you have any questions, contact the Health Canada ICH Secretariat.
Interested in our other consultations? Sign up and stay informed about topics that matter to you.